These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35788981)

  • 1. Evodiamine inhibits stemness and metastasis by altering the SOX9-β-catenin axis in non-small-cell lung cancer.
    Panda M; Biswal BK
    J Cell Biochem; 2022 Sep; 123(9):1454-1466. PubMed ID: 35788981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evodiamine potentiates cisplatin-induced cell death and overcomes cisplatin resistance in non-small-cell lung cancer by targeting SOX9-β-catenin axis.
    Panda M; Biswal S; Biswal BK
    Mol Biol Rep; 2024 Apr; 51(1):523. PubMed ID: 38630183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of JNK contributes to evodiamine-induced apoptosis and G2/M arrest in human colorectal carcinoma cells: a structure-activity study of evodiamine.
    Chien CC; Wu MS; Shen SC; Ko CH; Chen CH; Yang LL; Chen YC
    PLoS One; 2014; 9(6):e99729. PubMed ID: 24959718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein Kinase RNA-Like Endoplasmic Reticulum Kinase-Mediated Bcl-2 Protein Phosphorylation Contributes to Evodiamine-Induced Apoptosis of Human Renal Cell Carcinoma Cells.
    Wu WS; Chien CC; Chen YC; Chiu WT
    PLoS One; 2016; 11(8):e0160484. PubMed ID: 27483435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evodiamine suppresses Notch3 signaling in lung tumorigenesis via direct binding to γ-secretases.
    Yang X; Zhang Y; Huang Y; Wang Y; Qi X; Su T; Lu L
    Phytomedicine; 2020 Mar; 68():153176. PubMed ID: 32045841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evodiamine from Evodia rutaecarpa induces apoptosis via activation of JNK and PERK in human ovarian cancer cells.
    Chen TC; Chien CC; Wu MS; Chen YC
    Phytomedicine; 2016 Jan; 23(1):68-78. PubMed ID: 26902409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evodiamine induces G2/M arrest and apoptosis via mitochondrial and endoplasmic reticulum pathways in H446 and H1688 human small-cell lung cancer cells.
    Fang C; Zhang J; Qi D; Fan X; Luo J; Liu L; Tan Q
    PLoS One; 2014; 9(12):e115204. PubMed ID: 25506932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evodiamine, a novel inhibitor of the Wnt pathway, inhibits the self-renewal of gastric cancer stem cells.
    Wen Z; Feng S; Wei L; Wang Z; Hong D; Wang Q
    Int J Mol Med; 2015 Dec; 36(6):1657-63. PubMed ID: 26497016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evodiamine suppresses the progression of non-small cell lung carcinoma via endoplasmic reticulum stress-mediated apoptosis pathway
    Li Y; Wang Y; Wang X; Jin L; Yang L; Zhu J; Wang H; Zheng F; Cui H; Li X; Jia Y
    Int J Immunopathol Pharmacol; 2022; 36():3946320221086079. PubMed ID: 35388733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evodiamine Prevents Glioma Growth, Induces Glioblastoma Cell Apoptosis and Cell Cycle Arrest through JNK Activation.
    Wu WS; Chien CC; Liu KH; Chen YC; Chiu WT
    Am J Chin Med; 2017; 45(4):879-899. PubMed ID: 28514905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evodiamine exerts inhibitory roles in non‑small cell lung cancer cell A549 and its sub‑population of stem‑like cells.
    Lu X; Zhang W; Liu Y; Liu M
    Exp Ther Med; 2022 Dec; 24(6):746. PubMed ID: 36561974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evodiamine exerts anti-tumor effects against hepatocellular carcinoma through inhibiting β-catenin-mediated angiogenesis.
    Shi L; Yang F; Luo F; Liu Y; Zhang F; Zou M; Liu Q
    Tumour Biol; 2016 Sep; 37(9):12791-12803. PubMed ID: 27449032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOX9 regulated proliferation and apoptosis of human lung carcinoma cells by the Wnt/β-catenin signaling pathway.
    Guo YZ; Xie XL; Fu J; Xing GL
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4898-4907. PubMed ID: 30070325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evodiamine Exerts Anticancer Effects Against 143B and MG63 Cells Through the Wnt/β-Catenin Signaling Pathway.
    Yang S; Chen J; Tan T; Wang N; Huang Y; Wang Y; Yuan X; Zhang P; Luo J; Luo X
    Cancer Manag Res; 2020; 12():2875-2888. PubMed ID: 32425601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The omega-3 polyunsaturated fatty acid docosahexaenoic acid inhibits proliferation and progression of non-small cell lung cancer cells through the reactive oxygen species-mediated inactivation of the PI3K /Akt pathway.
    Yin Y; Sui C; Meng F; Ma P; Jiang Y
    Lipids Health Dis; 2017 May; 16(1):87. PubMed ID: 28468627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway.
    Huang JQ; Wei FK; Xu XL; Ye SX; Song JW; Ding PK; Zhu J; Li HF; Luo XP; Gong H; Su L; Yang L; Gong LY
    J Transl Med; 2019 May; 17(1):143. PubMed ID: 31060551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposure of piperlongumine attenuates stemness and epithelial to mesenchymal transition phenotype with more potent anti-metastatic activity in SOX9 deficient human lung cancer cells.
    Tripathi SK; Sahoo RK; Biswal BK
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Aug; 397(8):5631-5647. PubMed ID: 38280008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evodiamine, a plant alkaloid, induces calcium/JNK-mediated autophagy and calcium/mitochondria-mediated apoptosis in human glioblastoma cells.
    Liu AJ; Wang SH; Chen KC; Kuei HP; Shih YL; Hou SY; Chiu WT; Hsiao SH; Shih CM
    Chem Biol Interact; 2013 Sep; 205(1):20-8. PubMed ID: 23774672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evodiamine, a Novel NOTCH3 Methylation Stimulator, Significantly Suppresses Lung Carcinogenesis
    Su T; Yang X; Deng JH; Huang QJ; Huang SC; Zhang YM; Zheng HM; Wang Y; Lu LL; Liu ZQ
    Front Pharmacol; 2018; 9():434. PubMed ID: 29765324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOX9 promotes epidermal growth factor receptor-tyrosine kinase inhibitor resistance via targeting β-catenin and epithelial to mesenchymal transition in lung cancer.
    Tripathi SK; Biswal BK
    Life Sci; 2021 Jul; 277():119608. PubMed ID: 33989664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.